NM_005422.4:c.5296G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005422.4(TECTA):c.5296G>A(p.Val1766Met) variant causes a missense change. The variant allele was found at a frequency of 0.000121 in 1,607,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000419 AC: 10AN: 238730Hom.: 0 AF XY: 0.0000467 AC XY: 6AN XY: 128592
GnomAD4 exome AF: 0.000129 AC: 187AN: 1454976Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 98AN XY: 722752
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
proposed classification - variant undergoing re-assessment, contact laboratory -
Inborn genetic diseases Uncertain:1
The c.5296G>A (p.V1766M) alteration is located in exon 16 (coding exon 16) of the TECTA gene. This alteration results from a G to A substitution at nucleotide position 5296, causing the valine (V) at amino acid position 1766 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at